Baker Bros. Advisors’s Albireo Pharma Inc ALBO Stock Holding History

Baker Bros. Advisors’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-104,521	Closed	-$2.43M	–	120
2021 Q4	$2.43M	Sell	104,521 -307,945	-75%	-$8.19M	0.01%	104
2021 Q3	$12.9M	Hold	412,466	–	–	0.06%	71
2021 Q2	$14.5M	Hold	412,466	–	–	0.06%	70
2021 Q1	$14.5M	Hold	412,466	–	–	0.06%	68
2020 Q4	$15.5M	Sell	412,466 -136,581	-25%	-$4.97M	0.06%	65
2020 Q3	$18.3M	Buy	549,047 +180,000	+49%	+$5.24M	0.07%	55
2020 Q2	$9.78M	Hold	369,047	–	–	0.04%	62
2020 Q1	$6.04M	Buy	369,047 +119,047	+48%	+$2.62M	0.04%	61
2019 Q4	$6.36M	Hold	250,000	–	–	0.03%	63
2019 Q3	$5M	Hold	250,000	–	–	0.03%	61
2019 Q2	$8.06M	Hold	250,000	–	–	0.05%	56
2019 Q1	$8.05M	Hold	250,000	–	–	0.05%	52
2018 Q4	$6.13M	Hold	250,000	–	–	0.05%	54
2018 Q3	$8.24M	Hold	250,000	–	–	0.05%	56
2018 Q2	$8.88M	Hold	250,000	–	–	0.07%	57
2018 Q1	$8.14M	Buy	250,000 +50,000	+25%	+$1.68M	0.07%	66
2017 Q4	$5.12M	Hold	200,000	–	–	0.04%	76
2017 Q3	$4.19M	Hold	200,000	–	–	0.03%	81
2017 Q2	$4.12M	Buy	+200,000	New	+$4.1M	0.04%	67
2015 Q2	–	Sell	-1,006	Closed	-$36K	–	133
2015 Q1	$36K	Buy	+1,006	New	+$42.4K	﹤0.01%	130
2013 Q3	–	Sell	-7,663	Closed	-$961K	–	84
2013 Q2	$961K	Buy	+7,663	New	+$797K	0.02%	68

Other funds holding ALBO

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baker Bros. Advisors's ALBO Position: Q1 2022 in Review

Baker Bros. Advisors sold out of Albireo Pharma Inc (ALBO) in Q1 2022, closing a stake of 104,521 shares — an estimated $2.43M sold.

Baker Bros. Advisors first reported a position in ALBO in Q2 2013 and held it in 21 quarters. The position peaked at $18.3M in Q3 2020. 109 funds tracked by Wall St. Rank hold ALBO as of Q1 2022.

Baker Bros. Advisors reported no remaining Albireo Pharma Inc position as of Q1 2022 after selling out during the quarter.
Baker Bros. Advisors sold 104,521 Albireo Pharma Inc shares in Q1 2022, an estimated $2.43M.
Baker Bros. Advisors first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 21 quarters.
Baker Bros. Advisors's Albireo Pharma Inc position peaked at $18.3M in Q3 2020.
109 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2022.

Based on Baker Bros. Advisors's 13F filing for Q1 2022, filed 16 May 2022.